Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
2018
2018
Plum Alley Ventures Company is deploying over $1 Billion in Economic Transformative Value across capital stages investing at the intersection of frontier innovation and gender diversity across founders and capital allocators/GPs. As founding partner, I spearhead our strategy and investments across our Venture Funds and Direct Investing Syndicate businesses. We have deployed $100 Million with 100% gender diverse founders and female GPs across deep-tech, medical breakthroughs, climate and ESG, infrastructure and AI. We offer a novel venture platform across value creation to liquidity for LPs, Institutions, Family Offices and individual investors to invest in early to late stage private companies that are transforming the world and "Future Proofing" legacy industries. 2 EXITS. 2 UNICORNS. 5 BREAKOUT INVESTMENTS. ∙ MAMMOTH BIOSCIENCES (mammoth.bio) ∙ EINRIDE (einride.tech) ∙ AIR PROTEIN (airprotein.com) ∙ ACLIMA (aclima.io) ∙ AIFI (aifi.com) ∙ KETOS (ketos.co) ∙ DILIGENT ROBOTICS (diligentrobots.com) ∙ ONE CONCERN (oneconcern.com) ∙ EVRNU (evrnu.com) ∙ EPIBONE (epibone.com) ∙ NODE (hello.node.io) - EXIT ∙ THINK CERCA (thinkcerca.com) ∙ ASHVATTHA THERAPEUTICS (avttx.com)
2018
2018
Board of Director and Chair of the Angel Investing Committee and Annual TiE NY Pitch Competition. TiE Global has bestowed Lifetime Achievement Awards to Bill Gates, Michael Seibel (Y Combinator) and Tessier Lavigne (Stanford President). TiE is a non-profit, global community welcoming entrepreneurs from all over the world. We believe in the power of ideas to change the face of entrepreneurship and growing business through our five pillars; mentoring, networking, education, incubating and funding. TiE was founded in 1992 and currently is the world’s largest entrepreneurial organization.
2016 - 2018
2016 - 2018
Jopwell is a proprietary SaaS platform for diversity recruiting backed by Andreessen Horowitz, Kapor Capital, Omidyar Network, Valar Ventures, Cue Ball, SJF. Avantika worked with leadership to secure series A (total $12M in VC funding) along with: Leadership/Operations: ▪️ Implemented company KPIs focused on Revenue and Growth for a two sided platform ▪️ Restructured organization (first stage towards functions; second stage towards business units) Growth/Product: ▪️ Doubled platform/community growth rate in four months; significantly reduced CAC/CPC ▪️ Built performance marketing team; native ads, look-a-likes, multi channel acquisition ▪️ Built MMM (marketing mix) and channel attribution models ▪️ Scrum/Aigle framework - sprints, building iterative product to support SaaS & growth hacks Revenue/Partnership: ▪️ Increased ARR 2x; Product line revenue (Enterprise, SMB and Events (scaled networking)) ▪️ Worked with team to implement a specialized approach towards sales (SDR / ICP) ▪️ Salesforce implementation - sales / AM and community growth / CRM funnel ▪️ Secured partnerships - universities, SIGs, sports/tech industry; affiliate growth marketing ▪️ Closed largest sale/partnership - multi year enterprise client
2016 - 2018
2016 - 2018
There is No Balance. There is Juggling | Avantika Daing | TEDxChandigarh Avantika talks about the myth of balance in work-life. Her message is that one needs to keep juggling. So, learn to keep the balls up. Avantika has built multiple and diverse business across consumer technology, healthcare and biotech with IPO exit, M&As, and venture investment experience. With 25+ years of management experience, Avantika brings her expertise as an executive leader across marketing, growth strategy, product development and operations for both startups and Fortune 500 companies. Prior to Chief Revenue Officer of Jopwell, Avantika was the Senior Vice President and General Manager of Growth and Operations at Zomato, a global search and discovery restaurant platform. Under her leadership, she helped Zomato/UrbanSpoon scale to be the largest food discovery platform in the United States, valued at over a billion dollars. She also helped the founders of a first-to-market biotech firm to a IPO exit at a $735 Million market capitalization in three years. https://www.youtube.com/watch?v=EBDOk3X7JAc
2015 - 2016
2015 - 2016
$12.2B IPO valuation (June 2021). Under my leadership, Zomato, was valued at $1.2B and expanded as a global food tech company across 23 countries as the largest restaurant search and discovery platform (directly responsible for 120+ million monthly users, 10 million reviews, 1.5 million restaurants). Raised VC funding $225M, managed USA P&L, marketing, strategy, consumer growth, partnerships/business development, data/content and recruiting. Built and scaled the company's first enterprise SaaS product. Additionally: Leadership/Operations: ▪️ Appointed by leadership to lead the USA operations post acquisition of Urbanspoon (IAC) ▪️ Acquired Urbanspoon, MaplePOS and NexTable ▪️ Implemented 6 hub-spoke cities to manage monthly burn and strategic product deployment ▪️ Motivated and empowered a 250 cross functional team - 70% millennials ▪️ Developed 4 business units - content, community engagement, partnerships, enterprise sales Growth/Product: ▪️ 45M monthly visitors (more than doubled via growth and acquisition) ▪️ Aigle framework for iterative pdt deployment - search, ratings, reviews, enterprise reporting ▪️ Introduced company’s 1st enterprise SaaS product - table reservations, POS, digital wallet ▪️ Introduced freemium ROI analytical product - marketing and advertising platforms ▪️ Developed prime position - 1st integrated discovery platform to restaurant’s technology backend to create operational efficiency and personalized/data marketing Revenue/ARR/Partnerships: ▪️ Revenue - advertising, search, online ordering and enterprise (SaaS reservation/POS) ▪️ 2016 Revenue $49M - 80% growth ▪️ P&L and KPI discipline across cities - weekly, monthly ▪️ Partnerships (multi channel): mayor offices, festivals, consumer tech and mobility platforms
2011 - 2014
2011 - 2014
SquareKey.com, a content driven curated marketplace for US contemporary brands providing access to international markets with regulated FDI policies (India/Malaysia). VC backed / Acquhire. Leadership/Operations: ▪️ Created India’s first content driven e-retail lifestyle site with exclusive brand partnerships (BCBG, Nanette Lepore, Nicole Miller, etc) via SaaS subscription ▪️ Scaled a cross-boarder, international multidisciplinary team of 25 between New York and India ▪️ Established ourselves as the Net-A-Porter of India's aspirational class - "Unlock the World" Growth/Product: ▪️ Grew business 35% month on month ▪️ Organic acquisition - loyal customers who were so passionate about our brand/service that they became our sales agent driving a "tupper-ware party" sales model ▪️ Monthly events: promoting offline community building with online ecommerce transaction Revenue: ▪️ 70% margins ▪️ $100k-$150k monthly top line ▪️ 90 out of 120 leading brands exclusively on platform ▪️ Demand driven revenue model - no inventory risk
2002 - 2009
2002 - 2009
▪️ First commercial drug, Macugen, to treat blindness caused by aging and diabetes. ▪️ IPOed on NASDAQ with $735MM market cap within 3 years of inception of company ▪️ 1st commercial employee, worked with founders to get company from clinical trial to revenue / IPO ▪️ Exceeded revenue goal by 125% ▪️ Led and managed marketing, business intelligence, life cycle management with an interdisciplinary 35 member team ▪️ Acquired by OSI Pharmaceuticals (OSIP) - required to stay on acquisition team 2008-2009
1998 - 2001
1998 - 2001
Worked in multiple areas of business with P&L responsibility across Consumer Products, Pharmaceutical and Biotechnology. CPG: Part of the management team to divest the consumer products business -- ▪️ Developed Marketing Mix Modeling, channel attribution and Volume Forecast Models with insights data for Herbal Essences, Keri and Viactic ▪️ Ayuvera (a line of skincare products that I conceived, built, led and sold as part of the divestiture) Pharamceuticals: managed consumer communication and marketing for Pravachol Biotechnology: Commercial leader for first biotech deal in the US; Erbitux (BMS/Imclone deal). ▪️ Managed agency and cross-company relationships ▪️ Brand development and co-marketing ▪️ Managed P&L, business intelligence and execution for the payor, physician, patient segments.
1995 - 1998
1995 - 1998
Brands: Bounty (Bounty SaS), Charmin, New Products (Olean/Olestra) Came on board as the managing account executive to then manage the brands P&L and business intelligence and analytics.
1994 - 1995
1994 - 1995